+4,281
British Columbia Vancouver, Canada, Canada
Contact this investorsIT (& TMT) • Media • AgroTech • Businesses Solutions • FinTech (& Financials services) • HealthTech (& Fitness) • Web Security (& Privacy) • Food & Beverage • Medical Devices (& Hospital Services) • Payments • SaaS • Healthcare (& Wellness) • Investment Management • Life Science • Mobile • Consumer • Pharmaceutical (& Medicine) • Diagnostics
TELUS Ventures is the venture capital arm of TELUS, a North American telecommunications company headquartered in Vancouver, Canada. The firm partners with privately held companies that offer unique technologies and innovative products that will accelerate growth initiatives within TELUS. The firm actively seeks synergistic investments in digital health, internet of things, big data, artificial intelligence, machine learning, security, managed information technology services, wireless, and next-generation network infrastructure.
Menlo Park, United States
Contact this investorsCosmetics (& Fashion) • IoT (& Wearables) • A.I. (& Big Data) • HealthTech (& Fitness) • Analytics • Healthcare (& Wellness) • Life Science • Pharmaceutical (& Medicine)
DigitalDx Ventures is a Venture Capital firm based in Menlo Park, California. The firm invests in the healthcare sector.
San Francisco California - San Francisco Bay Area - SF Bay Area New York - New York City, United States
Contact this investorsSoftware (Web Marketplace Saas..) • PropTech • Education • AgroTech • Businesses Solutions • FinTech (& Financials services) • Retail (& E-Commerce) • Sales (& Marketing) • Cosmetics (& Fashion) • A.I. (& Big Data) • HealthTech (& Fitness) • Blockchain (& Cryptos) • Analytics • AR/VR • Developer tools • Food & Beverage • Impact • Medical Devices (& Hospital Services) • Payments • Real Estate (& Construction) • SaaS • Healthcare (& Wellness) • Investment Management • LegalTech • Life Science • Mobile • Mobility • Online Social • Consumer • Pharmaceutical (& Medicine) • Woman Focused • Diagnostics
Primary Venture Partners is an early stage venture capital firm which makes seed investments in industry-transforming technology companies and reserve capital to follow initial investments across multiple financings. The firm focuses on investing in companies within the business products, business services, mobile, software, information technology, enterprise SaaS, nextgen commerce, manufacturing and energy sectors.
New York City, U.S.A.
Contact this investorsSoftware (Web Marketplace Saas..) • IT (& TMT) • Education • Businesses Solutions • FinTech (& Financials services) • Retail (& E-Commerce) • IoT (& Wearables) • CleanTech • A.I. (& Big Data) • Blockchain (& Cryptos) • Gaming (& eSports) • Investment Management • Life Science • Mobile
Artesian Capital Management is an alternative investment manager with an approach to early stage venture capital investments targeting both financial and strategic returns for 'High Net Worth Individuals', corporate and institutional investments. The firm invests in the media, healthcare, diagnostics and life sciences, web application, software, mobile, communications and information technology sectors
London, United Kingdom
Contact this investorsSoftware (Web Marketplace Saas..) • IT (& TMT) • Businesses Solutions • FinTech (& Financials services) • Retail (& E-Commerce) • CleanTech • A.I. (& Big Data) • HealthTech (& Fitness) • Developer tools • Medical Devices (& Hospital Services) • Robotics • SaaS • DeepTech • Healthcare (& Wellness) • Investment Management • Life Science • Mobility • Nanotechnology • Oncology • Consumer • Woman Focused
Founder & Managing Partner at Fuel Ventures
Fuel Ventures is a venture capital firm based in London, United Kingdom. The firm invests in companies operating in the SaaS, mobile, technology, and e-commerce sectors. The firm invests in the early and growth stage companies based in United Kingdom.
Geneva - London, United Kingdom
Contact this investorsSoftware (Web Marketplace Saas..) • PropTech • IT (& TMT) • Hospitality (& Events) • Media • BioTech • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • Retail (& E-Commerce) • Sales (& Marketing) • Entertainment (& Sports) • A.I. (& Big Data) • HealthTech (& Fitness) • Web Security (& Privacy) • Gaming (& eSports) • Analytics • Cloud Services (& Infrastructure) • Developer tools • Future Of Work • Food & Beverage • Insurance (& InsurTech) • Logistics (& Distribution) • Medical Devices (& Hospital Services) • Robotics • Real Estate (& Construction) • Healthcare (& Wellness) • Investment Management • Life Science • Mobile • Mobility • Nanotechnology • Oncology • Online Social • Consumer • Pharmaceutical (& Medicine) • Woman Focused
Index Ventures is a venture capital firm which specializes in seed, early stage, later stage and growth capital investments. The firm focuses on investing in companies based in Europe, operating in the biotechnology, retail, clean technology, media and life sciences sectors. It was founded in 1996 and is based in Geneva, Switzerland.
Index Ventures invests in multi-stage, transformative companies who are willing to challenge convention. The firm is especially dedicated to the information technology, clean technology, and life science sectors. They back the best and most ambitious entrepreneurs with a tight-knit collaborative partnership that retains a shared mission of seeing opportunity instead of obstacles. Index Ventures has teamed up with exceptional entrepreneurs in 39 cities around the world and have helped them grow into new regions. They provide a full-service partnership where they bring a lot of experience and expertise to the table.
In November 2022, they launched their second seed fund Origin II, a $300M fund focus on early-stage investing. It is $100m larger than Origin I, and is a highly collaborative fund, with seed-specific support, that works alongside solo GPs and angels, to help companies be best positioned for success.
San Francisco Bay Area - San Diego California - New York City, United States
Contact this investorsHealthTech (& Fitness) • Advertising • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Life Science • Consumer • Pharmaceutical (& Medicine) • Diagnostics
Founded in 2011, StartUp Health is a venture capital firm based in New York, New York. The firm invests in healthcare and healthcare technology sector.
Atlanta Georgia, United States
Contact this investorsSoftware (Web Marketplace Saas..) • IT (& TMT) • Media • Education • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • Retail (& E-Commerce) • Sales (& Marketing) • Entertainment (& Sports) • IoT (& Wearables) • A.I. (& Big Data) • HealthTech (& Fitness) • Gaming (& eSports) • Advertising • Autonomous vehicles (& Cars) • Cloud Services (& Infrastructure) • Developer tools • Food & Beverage • Insurance (& InsurTech) • Logistics (& Distribution) • Medical Devices (& Hospital Services) • Payments • SaaS • DeepTech • Healthcare (& Wellness) • Music • Investment Management • Life Science • Mobile • Mobility • Consumer • Woman Focused
BIP Capital is a venture capital firm based in Atlanta, Georgia. The firm was founded in 2007 and invests in companies operating in the information technology and healthcare sector.
Atlanta - San Francisco - Menlo Park, United States
Contact this investorsSoftware (Web Marketplace Saas..) • IT (& TMT) • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • A.I. (& Big Data) • HealthTech (& Fitness) • Web Security (& Privacy) • Food & Beverage • Insurance (& InsurTech) • Logistics (& Distribution) • Material Science • Real Estate (& Construction) • Investment Management • Life Science • Mobile • Oncology • Consumer • Pharmaceutical (& Medicine) • Restaurants
Accel-KKR is a private equity firm that seeks to invest in the mid-market software and technology enabled services firms. The firm specializes in minority-growth investments to buyouts, recapitalizations and going-private transactions. It is based in Menlo Park, California and was founded in 2000.
San Francisco Bay Area (CA) - Menlo Park, United States
Contact this investorsSoftware (Web Marketplace Saas..) • Other • IT (& TMT) • Education • BioTech • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • Energy • Retail (& E-Commerce) • Entertainment (& Sports) • CleanTech • A.I. (& Big Data) • HealthTech (& Fitness) • Cannabis • Web Security (& Privacy) • Cloud Services (& Infrastructure) • Developer tools • Future Of Work • Food & Beverage • Human Resources • Impact • Material Science • Medical Devices (& Hospital Services) • Robotics • Real Estate (& Construction) • SaaS • FoodTech • Healthcare (& Wellness) • Life Science • Mobile • Mobility • Nanotechnology • Oncology • Online Social • Consumer • Pharmaceutical (& Medicine) • Restaurants • Woman Focused • Diagnostics • Productivity
Mayfield Fund is a venture capital firm which specializes in seed, early stage, later stage and growth investments. It invests in companies based in the United States, Europe, India and China operating in the agribusiness, financial services, energy, data, communication, infrastructure, software, internet of things, clean energy, retail, business e-commerce and healthcare sectors. The firm was founded in 1969 and is based in Menlo Park, California.
Boston Massachusetts, United States
Contact this investorsSoftware (Web Marketplace Saas..) • IT (& TMT) • Media • BioTech • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • Energy • Retail (& E-Commerce) • Sales (& Marketing) • A.I. (& Big Data) • HealthTech (& Fitness) • Cannabis • Analytics • Cloud Services (& Infrastructure) • Future Of Work • Human Resources • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Life Science • Mobile • Consumer • Pharmaceutical (& Medicine) • Diagnostics
Polaris Venture Partners is a venture capital firm that invests in seed, early, later and expansion stage companies operating in the technology and healthcare sectors. The firm was founded in 1996 and is based in Boston, Massachusetts.
San Francisco California - Blockchain - Human capital - San Francisco Bay Area, United States
Contact this investorsSoftware (Web Marketplace Saas..) • IT (& TMT) • Media • BioTech • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • A.I. (& Big Data) • HealthTech (& Fitness) • Blockchain (& Cryptos) • Human Resources • Insurance (& InsurTech) • Logistics (& Distribution) • Medical Devices (& Hospital Services) • DeepTech • Healthcare (& Wellness) • Investment Management • Life Science • Pharmaceutical (& Medicine) • Diagnostics
DigiTx Partners is a venture capital firm founded in 2016 and is based in South San Francisco, California. The firm was launched as a joint venture by Astellas Pharma and MPM Capital. It invests in early-stage firms operating in the medicine and healthcare sectors.
The Life Sciences industry involves the study and application of biology and related sciences to develop products and technologies that improve human health and the environment. This includes biotechnology, pharmaceuticals, medical devices, and diagnostics. The global life sciences market was valued at approximately $1.5 trillion in 2020 and is projected to reach $2.4 trillion by 2027, growing at a CAGR of 6.7%.
The growth of this industry is driven by advancements in scientific research, increasing investment in healthcare innovation, and the rising prevalence of chronic diseases. These factors are propelling the life sciences industry to new heights, fostering the development of innovative products and technologies.
The life sciences industry has a significant impact on society by driving medical breakthroughs, improving patient outcomes, and promoting environmental sustainability. Its contributions are crucial in enhancing the quality of life and addressing global health challenges.
Biotechnology applications, such as gene editing and regenerative medicine, are enabling the development of personalized treatments and therapies. These advancements are revolutionizing healthcare by providing targeted and effective solutions for various health conditions.
Pharmaceuticals provide essential medications for the prevention and treatment of diseases, improving quality of life and life expectancy. The development and distribution of effective drugs are vital for managing and curing diseases.
Medical devices, including diagnostic tools and surgical instruments, support accurate diagnosis and effective treatment of health conditions. These tools are indispensable in modern healthcare, facilitating high-quality patient care.
Diagnostics, such as molecular and genetic testing, enable early detection and personalized medicine, enhancing the precision of healthcare interventions. Early and accurate diagnosis is key to effective treatment and improved patient outcomes.
The COVID-19 pandemic has underscored the importance of the life sciences industry, as researchers and companies rapidly developed vaccines, treatments, and diagnostic tests to combat the virus. This response highlights the industry's critical role in addressing global health emergencies.
The industry faces challenges related to regulatory approval, high research and development costs, and the need for ethical considerations in scientific advancements. Addressing these challenges is essential for the continued growth and success of the life sciences sector.
Despite these challenges, the potential benefits of life sciences innovations are immense. Continued investment and innovation in this sector are essential for driving growth. As technology continues to advance, the life sciences industry will play a crucial role in shaping the future of healthcare and environmental sustainability, providing innovative solutions that enhance human health and well-being.
To connect with VCs in the Life Science sector, target firms such as Sequoia Capital, Andreessen Horowitz, and OrbiMed. Research their investment portfolios to understand their focus areas and tailor your approach accordingly.
Networking through industry conferences, biotech summits, and life science forums can provide opportunities to meet VC partners. These events are essential for building relationships and understanding current investment trends in the life sciences sector.
When pitching, focus on demonstrating the market potential, technological innovation, and scalability of your life science solution. Be prepared to discuss your business model, customer acquisition strategies, and revenue projections in detail to highlight the feasibility and growth potential of your product.
Participating in demo days hosted by biotech accelerators or incubators can help you showcase your product to a broader audience of VCs. These events provide a platform to present your innovation and gain valuable feedback from potential investors.
Crafting a compelling story about your product’s impact and the problem it solves will resonate well with VC investors who are looking for high-growth potential startups. Emphasize the unique value proposition and real-world applications of your solution.
Following up with a comprehensive pitch deck that includes market analysis, go-to-market strategy, and potential exit opportunities can further strengthen your case. This demonstrates that you have a strategic plan for growth and sustainability.
Highlighting any strategic partnerships or collaborations with major research institutions or biotech companies can also add weight to your pitch. Demonstrating established connections can reassure VCs of your industry relevance and network strength.
Ensuring that you present a well-rounded team with expertise in both life sciences and business development will appeal to VCs looking for capable execution of your vision. A strong team is often a critical factor in investment decisions.
Exotic Orange & Angels Partners: Turning Financial Simplicity Into Investment SuccessChatNode.ai: Revolutionizing Communication with AI, A Success StoryInterview with the Founder of ZenLaw: An Angels Partners Success Story!Sell SaaS Success StoryAWA Success StoryAngels Partners helps The MVMNT Group raise $250k for Saas productTo connect with VCs in the Life Science sector, target firms such as Sequoia Capital, Andreessen Horowitz, and OrbiMed. These firms have a strong track record of investing in successful life science startups.
Sequoia Capital, known for backing companies like 23andMe and Guardant Health, focuses on high-growth potential and market disruption. Their investment strategy prioritizes transformative life science technologies.
Andreessen Horowitz, with investments in companies like Freenome and Apeel Sciences, looks for innovative life science solutions that can scale globally. Their portfolio reflects a commitment to cutting-edge innovations.
OrbiMed, a leading healthcare investment firm, seeks out startups with strong scientific foundations and significant market potential. They aim to support businesses that demonstrate robust growth and impactful innovations.
To connect with these VCs, research their investment portfolios and identify partners who have shown interest in your industry. Tailoring your approach based on their specific focus areas can enhance your chances of success.
Attend industry conferences, life science summits, and biotech forums where these VCs are likely to be present. These events provide valuable networking opportunities and visibility for your startup.
Participating in demo days hosted by life science accelerators or incubators can also provide exposure. These platforms allow you to showcase your innovation to potential investors and industry leaders.
When pitching to VCs, emphasize your startup’s market opportunity, technological innovation, and scalability. Clearly articulate how your solution addresses a significant need in the life science industry.
Crafting a compelling story about your product’s impact and the problem it solves will resonate well with VC investors. Highlight the unique value and potential market disruption your technology offers.
Follow up with a comprehensive pitch deck that includes market analysis, competitive landscape, and potential exit opportunities. This detailed presentation will help VCs understand your business and its prospects.
Highlighting any strategic partnerships or collaborations with major healthcare providers or research institutions can also add weight to your pitch. These partnerships can validate your technology and enhance its credibility.
Ensuring that you present a well-rounded team with expertise in both life science technology and business development will appeal to VCs looking for capable execution of your vision. A strong, experienced team is crucial for successful implementation and growth.
